NCT04413266View on ClinicalTrials.gov

Effects of Curcumin Supplementation in Patients With Chronic Kidney Disease on Peritoneal Dialysis

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 10, 2020

Primary Completion Date

October 5, 2023

Study Completion Date

October 5, 2023

Conditions
Chronic Kidney DiseasesPeritoneal DialysisHemodialysis
Interventions
DIETARY_SUPPLEMENT

Curcumin supplementation

The patients will receive 3 capsules per day containing 500mg of curcumin for 4 weeks

Trial Locations (1)

22260050

Denise Mafra, Rio de Janeiro

All Listed Sponsors
lead

Universidade Federal Fluminense

OTHER

NCT04413266 - Effects of Curcumin Supplementation in Patients With Chronic Kidney Disease on Peritoneal Dialysis | Biotech Hunter | Biotech Hunter